D. Jochmans

发表

Progress in human picornavirus research: New findings from the AIROPico consortium

S. Butcher, O. Landt, J. Neyts, 2019, Antiviral research.

Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture

T. Bestebroer, J. Neyts, E. Snijder, 2014, Antimicrobial Agents and Chemotherapy.

Intervention strategies for emerging viruses: use of antivirals

J. Neyts, Y. Debing, D. Jochmans, 2013, Current Opinion in Virology.

Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects

J. Dye, J. Wikswo, J. Neyts, 2021, bioRxiv.

Indolopyridones Inhibit Human Immunodeficiency Virus Reverse Transcriptase with a Novel Mechanism of Action

K. Hertogs, J. Deval, D. Jochmans, 2006, Journal of Virology.

MAPPIT (MAmmalian Protein-Protein Interaction Trap) as a tool to study HIV reverse transcriptase dimerization in intact human cells.

I. Lemmens, J. Tavernier, S. Lievens, 2008, Journal of virological methods.

Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues

J. Neyts, D. Schols, E. Vanderlinden, 2021, Antiviral Research.

CultureCoronavirus Replication in Cell Inhibitors of Middle East Respiratory Library Identifies Four Small-Molecule Screening of an FDA-Approved Compound

T. Bestebroer, E. Snijder, D. Jochmans, 2014 .

Difluoromethylbenzoxazole pyrimidine thioether derivatives: a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.

J. Unge, M. Médebielle, E. Arnoult, 2011, Journal of medicinal chemistry.

TMC125 Displays a High Genetic Barrier to the Development of Resistance: Evidence from In Vitro Selection Experiments

R. Pauwels, K. Andries, M. de Béthune, 2005, Journal of Virology.

Resistance Mutations in Human Immunodeficiency Virus Type 1 Integrase Selected with Elvitegravir Confer Reduced Susceptibility to a Wide Range of Integrase Inhibitors

K. Hertogs, Peggy Geluykens, Inge Vereycken, 2008, Journal of Virology.

Antiviral activity of [1,2,3]triazolo[4,5‐d]pyrimidin‐7(6H)‐ones against chikungunya virus targeting the viral capping nsP1

B. Coutard, E. Decroly, L. Delang, 2017, Antiviral research.

Synthesis, Structure–Activity Relationships, and Antiviral Profiling of 1-Heteroaryl-2-Alkoxyphenyl Analogs as Inhibitors of SARS-CoV-2 Replication

A. Marchand, R. Hilgenfeld, E. Decroly, 2022, Molecules.

The Urtica Dioica Agglutinin Prevents Rabies Virus Infection in a Muscle Explant Model

J. Neyts, E. V. Van Damme, A. Fooks, 2021, bioRxiv.

Chemical Evolution of Antivirals Against Enterovirus D68 through Protein‐Templated Knoevenagel Reactions

G. Wolber, J. Neyts, J. Rademann, 2021, Angewandte Chemie.

Betulonic acid derivatives inhibiting coronavirus replication in cell culture via the nsp15 endoribonuclease

L. Naesens, W. Dehaen, A. Voet, 2020, bioRxiv.

Identification of inhibitors of SARS-CoV-2 3CL-Pro enzymatic activity using a small molecule in-vitro repurposing screen

F. Musiani, Daniela Iaconis, V. Summa, 2020, bioRxiv.

SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging

R. Hilgenfeld, J. Neyts, W. Młynarski, 2020, Nature Chemical Biology.

Betulonic Acid Derivatives Interfering with Human Coronavirus 229E Replication via the nsp15 Endoribonuclease

L. Naesens, W. Dehaen, A. Voet, 2021, Journal of medicinal chemistry.

Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus Activity

J. Neyts, D. Schols, E. Tramontano, 2022, ACS medicinal chemistry letters.

Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity

J. Neyts, E. Snijder, D. Jochmans, 2015, Bioorganic & Medicinal Chemistry Letters.

Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase

J. Neyts, J. Kowalska, J. Jemielity, 2021, Antiviral Research.

A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents

J. Neyts, P. Gallay, A. Chatterjee, 2021, bioRxiv.

Synthesis, characterization, molecular docking, and anticancer activities of new 1,3,4-oxadiazole-5-fluorocytosine hybrid derivatives

J. Neyts, M. Zahouily, D. Jochmans, 2022, Journal of Molecular Structure.

Differential antiviral activities of RSV inhibitors in human airway epithelium

A. Marchand, J. Neyts, M. Boon, 2018, bioRxiv.

Differential antiviral activities of respiratory syncytial virus (RSV) inhibitors in human airway epithelium

A. Marchand, J. Neyts, M. Boon, 2018, The Journal of antimicrobial chemotherapy.

Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern

P. Maes, E. André, J. Neyts, 2021, bioRxiv.

Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19

G. Moureau, B. Weynand, E. Chatelain, 2022, Microorganisms.

SARS-CoV-2 Virion Infectivity and Cytokine Production in Primary Human Airway Epithelial Cells

J. Neyts, D. Schols, S. Claes, 2022, Viruses.

A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection

B. Weynand, J. Neyts, D. Jochmans, 2022, bioRxiv.

Evaluation of the anti-SARS-CoV-2 properties of essential oils and aromatic extracts

R. Hilgenfeld, S. Olsen, J. Neyts, 2021, Scientific reports.

A novel kindred with inherited STAT2 deficiency and severe viral illness.

J. Casanova, A. Liston, Shen-Ying Zhang, 2017, The Journal of allergy and clinical immunology.

Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial

B. Weynand, G. Meyfroidt, W. Janssens, 2021, EBioMedicine.

A novel high-throughput cellular screening assay for the discovery of HIV-1 integrase inhibitors.

R. Clayton, M. Van Loock, G. Meersseman, 2012, Journal of virological methods.

Synthesis of new 3-acetyl-1,3,4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agents

J. Neyts, G. Andrei, R. Snoeck, 2022, Molecular diversity.

Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral.

X. de Lamballerie, P. Herdewijn, L. Delang, 2014, The Journal of antimicrobial chemotherapy.

Rapid and convenient assays to assess potential inhibitory activity on in vitro hepatitis A replication.

J. Neyts, Y. Debing, D. Jochmans, 2013, Antiviral research.

Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS-CoV-2 Main Protease

Hannah J. Maple, R. Hilgenfeld, J. Neyts, 2022, Journal of medicinal chemistry.

Itraconazole for COVID-19: Preclinical Studies and a Proof-of-Concept Pilot Clinical Study

B. Weynand, G. Meyfroidt, W. Janssens, 2020, SSRN Electronic Journal.

Cytopathic SARS-CoV-2 screening on VERO-E6 cells in a large-scale repurposing effort

C. Collard, Daniela Iaconis, V. Summa, 2022, Scientific data.

Pyrimethamine inhibits rabies virus replication in vitro

J. Neyts, S. Rogée, D. Jochmans, 2019, Antiviral research.

Antiviral Activity of Favipiravir (T-705) against a Broad Range of Paramyxoviruses In Vitro and against Human Metapneumovirus in Hamsters

R. Fouchier, J. Neyts, S. Smits, 2016, Antimicrobial Agents and Chemotherapy.

ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model

A. Marchand, C. Liu, J. Neyts, 2021, bioRxiv.

Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patients

P. Mombaerts, Mona Khan, J. Neyts, 2022, Neuron.

Regioselective convergent synthesis of 2-arylidene thiazolo[3,2-a]pyrimidines as potential anti-chikungunya agents

T. Clark, J. Neyts, Muhammad A. Alsherbiny, 2020, RSC advances.

The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern

B. Weynand, E. Chatelain, J. Neyts, 2021, Nature Communications.

Rational design of novel nucleoside analogues reveals potent antiviral agents for EV71.

A. Brancale, J. Neyts, D. Jochmans, 2022, European journal of medicinal chemistry.

The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor In Vitro and Confer Resistance To Nirmatrelvir

P. Maes, A. Marchand, J. Neyts, 2022, bioRxiv.

Nirmatrelvir-resistant SARS-CoV-2 is efficiently transmitted in Syrian hamsters

B. Weynand, J. Neyts, N. Ebert, 2022, bioRxiv.

Development of a robust and convenient dual-reporter high-throughput screening assay for SARS-CoV-2 antiviral drug discovery

J. Neyts, Manon Laporte, P. Leyssen, 2022, Antiviral Research.

The path towards effective antivirals against rabies

J. Neyts, D. Jochmans, 2017, Vaccine.

Identification of HIV-1 reverse transcriptase inhibitors using a scintillation proximity assay.

M. Van Loock, D. Jochmans, T. Ivens, 2013, Methods in molecular biology.

Indolopyridones Inhibit Human Immunodeﬁciency Virus Reverse Transcriptase with a Novel Mechanism of Action (cid:1)

K. Hertogs, J. Deval, D. Jochmans, 2006 .

Mannitol treatment is not effective in therapy of rabies virus infection in mice.

N. Tordo, A. Osterhaus, J. Neyts, 2017, Vaccine.

Human Immunodeficiency Virus Type 1 Non-Nucleoside Reverse Transcriptase Inhibitors

E. Arnoult, J. Guillemont, D. Jochmans, 2009 .

Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2

Kaixian Chen, Hualiang Jiang, Yechun Xu, 2021, Journal of medicinal chemistry.

Discovery of novel furo[2,3‐d]pyrimidin‐2‐one–1,3,4‐oxadiazole hybrid derivatives as dual antiviral and anticancer agents that induce apoptosis

J. Neyts, M. Zahouily, G. Andrei, 2021, Archiv der Pharmazie.

Novel HIV-1 reverse transcriptase inhibitors.

D. Jochmans, 2008, Virus research.

Synthesis, X-ray crystallographic analysis, DFT studies and biological evaluation of triazolopyrimidines and 2-anilinopyrimidines

J. Neyts, Muhammad A. Alsherbiny, Mohamed Fares, 2021, Journal of Molecular Structure.

Drug candidates and model systems in respiratory syncytial virus antiviral drug discovery

J. Neyts, D. Jochmans, E. Heylen, 2017, Biochemical pharmacology.

In vitro activity of itraconazole against SARS‐CoV‐2

S. Ciesek, M. Van Loock, J. Cinatl, 2020, bioRxiv.

Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2

D. Lambrechts, E. Vanstreels, P. Maes, 2021, Nature Genetics.

Development and optimization of a high‐throughput screening assay for in vitro anti‐SARS‐CoV‐2 activity: Evaluation of 5676 Phase 1 Passed Structures

S. Ciesek, Christophe Buyck, M. Van Loock, 2022, bioRxiv.

Kobophenol A Inhibits Binding of Host ACE2 Receptor with Spike RBD Domain of SARS-CoV-2, a Lead Compound for Blocking COVID-19

O. Acevedo, J. Neyts, P. Leyssen, 2021, The journal of physical chemistry letters.

Norovirus: Targets and tools in antiviral drug discovery

J. Neyts, D. Jochmans, J. Rocha-Pereira, 2014, Biochemical Pharmacology.

Inhibition of the Replication of Different Strains of Chikungunya Virus by 3-Aryl-[1,2,3]triazolo[4,5- d]pyrimidin-7(6 H)-ones.

L. Ng, A. Pérez‐Sánchez, L. Delang, 2018, ACS infectious diseases.

The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection

B. Coutard, E. Decroly, L. Delang, 2016, Scientific Reports.

New HSV-1 Anti-Viral 1′-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety

J. Neyts, V. Zarubaev, A. Hanganu, 2019, Molecules.

Formation of a Quaternary Complex of HIV-1 Reverse Transcriptase with a Nucleotide-competing Inhibitor and Its ATP Enhancer*

J. Bernatchez, M. Nijhuis, D. Jochmans, 2013, The Journal of Biological Chemistry.

Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Cells by Debio-025, a Novel Cyclophilin Binding Agent

R. Ptak, E. De Clercq, B. Rosenwirth, 2008, Antimicrobial Agents and Chemotherapy.

TMC278, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI), Active against Wild-Type and NNRTI-Resistant HIV-1

Dirk Jochmans, Hilde Azijn, Gaston Picchio, 2009, Antimicrobial Agents and Chemotherapy.

TMC114, a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor Active against Protease Inhibitor-Resistant Viruses, Including a Broad Range of Clinical Isolates

Dirk Jochmans, Hilde Azijn, Rudi Pauwels, 2005, Antimicrobial Agents and Chemotherapy.

The Viral Polymerase Inhibitor 2′-C-Methylcytidine Inhibits Norwalk Virus Replication and Protects against Norovirus-Induced Diarrhea and Mortality in a Mouse Model

J. Neyts, E. Verbeken, Y. Debing, 2013, Journal of Virology.

Title : 1 The viral polymerase inhibitor 2 ’-C-methylcytidine inhibits Norwalk 2 virus replication and protects against norovirus-induced diarrhea and 3 mortality in a mouse model 4

J. Neyts, E. Verbeken, Y. Debing, 2013 .

Inhibition of norovirus replication by the nucleoside analogue 2'-C-methylcytidine.

J. Neyts, I. Costa, P. Leyssen, 2012, Biochemical and biophysical research communications.

Mutations M184V and Y115F in HIV-1 Reverse Transcriptase Discriminate against “Nucleotide-competing Reverse Transcriptase Inhibitors”*

S. L. Le Grice, D. Jochmans, E. Tchesnokov, 2008, Journal of Biological Chemistry.

Patients with Discordant Responses to Antiretroviral Therapy Have Impaired Killing of HIV-Infected T Cells

G. Bren, A. Badley, J. Angel, 2010, PLoS pathogens.

STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters

P. Maes, J. Matthijnssens, M. Van Ranst, 2020, Nature Communications.

Identification of TMEM106B as proviral host factor for SARS-CoV-2

E. Vanstreels, P. Maes, J. Neyts, 2020, bioRxiv.

SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids

Ivan G. Costa, Vincent A. Voelz, Matthew F. D. Hurley, 2021, Cell Stem Cell.

Rational modifications, synthesis and biological evaluation of new potential antivirals for RSV designed to target the M2-1 protein.

A. Brancale, J. Neyts, D. Jochmans, 2020, Bioorganic & medicinal chemistry.

Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines

J. Casanova, S. Seligman, C. Rice, 2019, The Journal of experimental medicine.

The Urtica Dioica Agglutinin Prevents Rabies Virus Infection in a Muscle Explant Model

J. Neyts, E. V. Van Damme, A. Fooks, 2021, bioRxiv.

A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses

James A. Geraets, S. Butcher, J. A. Geraets, 2019, PLoS biology.

Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model

J. Lammertyn, N. Callewaert, J. Neyts, 2021, bioRxiv.

Favipiravir (T-705) inhibits in vitro norovirus replication.

J. Neyts, P. Leyssen, K. Dallmeier, 2012, Biochemical and biophysical research communications.

Antiviral treatment efficiently inhibits chikungunya virus infection in the joints of mice during the acute but not during the chronic phase of the infection.

L. Delang, J. Neyts, E. Verbeken, 2018, Antiviral research.

Prophylactic treatment with the nucleoside analogue 2'-C-methylcytidine completely prevents transmission of norovirus.

J. Neyts, D. Jochmans, J. Rocha-Pereira, 2015, The Journal of antimicrobial chemotherapy.

The Enterovirus Protease Inhibitor Rupintrivir Exerts Cross-Genotypic Anti-Norovirus Activity and Clears Cells from the Norovirus Replicon

R. Hilgenfeld, J. Neyts, Q. Ma, 2014, Antimicrobial Agents and Chemotherapy.

Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry

M. Scholle, C. Liu, J. Neyts, 2020, Antiviral Research.

Discovery of pan-ErbB inhibitors protecting from SARS-CoV-2 replication, inflammation, and lung injury by a drug repurposing screen.

J. Dye, J. Neyts, B. Pinsky, 2021, bioRxiv : the preprint server for biology.

MAPPIT as a high-throughput screening assay for modulators of protein-protein interactions in HIV and HCV.

J. Tavernier, S. Lievens, R. Clayton, 2012, Methods in molecular biology.

Identification of Polyphenol Derivatives as Novel SARS-CoV-2 and DENV Non-Nucleoside RdRp Inhibitors

Dongwei Kang, P. Zhan, Xinyong Liu, 2022, Molecules.

Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses

J. Lennerstrand, J. Kihlberg, Å. Lundkvist, 2022, Journal of the American Chemical Society.

A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE

J. Neyts, P. Leyssen, D. Jochmans, 2012, Journal of Virological Methods.

NNRTI-Resistant HIV-1 Active against Wild-Type and Reverse Transcriptase Inhibitor ( NNRTI ) , TMC 278 , a Next-Generation Nonnucleoside

D. Jochmans, J. Vingerhoets, G. Picchio, 2010 .

STAT2 signaling as double-edged sword restricting viral dissemination but driving severe pneumonia in SARS-CoV-2 infected hamsters

P. Maes, J. Matthijnssens, M. Van Ranst, 2020, bioRxiv.

Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen

F. Musiani, Daniela Iaconis, V. Summa, 2021, ACS pharmacology & translational science.

Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects

J. Dye, J. Wikswo, J. Neyts, 2023, bioRxiv.

An affinity-enhanced, broadly neutralizing heavy chain–only antibody protects against SARS-CoV-2 infection in animal models

P. Maes, N. Callewaert, B. Weynand, 2021, Science Translational Medicine.

Drug development of an affinity enhanced, broadly neutralizing heavy chain-only antibody that restricts SARS-CoV-2 in rodents

P. Maes, N. Callewaert, B. Weynand, 2021, bioRxiv.

Nirmatrelvir-resistant SARS-CoV-2 is efficiently transmitted in female Syrian hamsters and retains partial susceptibility to treatment

B. Weynand, J. Neyts, N. Ebert, 2023, Nature communications.

The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model

B. Weynand, J. Neyts, P. Augustijns, 2021, EBioMedicine.

Intranasal administration of convalescent plasma protects against SARS-CoV-2 infection in hamsters

B. Weynand, J. Neyts, V. Compernolle, 2023, eBioMedicine.

Open Science Discovery of Potent Non-Covalent SARS-CoV-2 Main Protease Inhibitors

David D. L. Minh, Vincent A. Voelz, Matthew F. D. Hurley, 2023, bioRxiv.

Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease

H. Kräusslich, B. Müller, D. Jochmans, 2010, Retrovirology.

HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect

B. Weynand, P. Proost, L. Delang, 2022, Antiviral Research.

Nelfinavir markedly improves lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect

B. Weynand, L. Delang, J. Neyts, 2021, bioRxiv.

The combined treatment of Molnupiravir and Favipiravir results in a marked potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model

B. Weynand, J. Neyts, A. Chatterjee, 2020, bioRxiv.

Bicyclic and Tricyclic "Expanded" Nucleobase Analogues of Sofosbuvir: New Scaffolds for Hepatitis C Therapies.

J. Neyts, J. Paeshuyse, D. Jochmans, 2015, ACS Infectious Diseases.

1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors.

A. Loregian, J. Neyts, Serena Massari, 2021, European journal of medicinal chemistry.

Identification of inhibitors of SARS-CoV-2 3CL-Pro enzymatic activity using a small molecule in-vitro repurposing screen

F. Musiani, Daniela Iaconis, J. Neyts, 2020 .

Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen

F. Musiani, Daniela Iaconis, J. Neyts, 2021, ACS Pharmacology & Translational Science.

Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase

J. Neyts, J. Kowalska, J. Jemielity, 2021, Antiviral Research.

Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects

J. Dye, J. Wikswo, J. Neyts, 2023, The Journal of clinical investigation.

Pan-ErbB inhibition protects from SARS-CoV-2 replication, inflammation, and injury

Aarthi, J. Neyts, B. Pinsky, 2021 .

Favipiravir (T-705) inhibits in vitro norovirus replication.

J. Neyts, P. Leyssen, K. Dallmeier, 2012, Biochemical and biophysical research communications.

SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids

Ivan G. Costa, Vincent A. Voelz, Matthew F. D. Hurley, 2021, Cell Stem Cell.

Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline: caution is warranted

J. Neyts, Koen Sedeyn, L. Vandekerckhove, 2024, EBioMedicine.

A Novel Method—Amenable for High-throughput Screening Purposes—to Quantify Antiviral Activity Against Viruses that Induce Limited CPE

Dirk Jochmans, Bernadette G. van den Hoogen, Pieter Leyssen, 2011, Antiviral Research.

Design, synthesis, and molecular modeling studies of novel 2-quinolone-1,2,3-triazole-α-aminophosphonates hybrids as dual antiviral and antibacterial agents.

D. Jochmans, S. de Jonghe, Fatiha Benkhalti, 2024, European journal of medicinal chemistry.